Department of Otorhinolaryngology - Head and Neck Surgery, General Hospital of Athens "Hippokration", National and Kapodistrian University of Athens, Athens, Greece.
Department of Otorhinolaryngology - Head and Neck Surgery, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Eur Arch Otorhinolaryngol. 2021 May;278(5):1429-1441. doi: 10.1007/s00405-020-06420-x. Epub 2020 Oct 16.
PURPOSE: Paranasal sinus osteomas are slow-growing, benign bony tumours that when larger than 30 mm, they are termed 'gigantic'. Special considerations apply for tumours of this calibre, and their rarity renders their management fairly controversial. This study seeks to contribute to an increased understanding concerning their management by presenting a 12-year experience from a single institution. METHODS: Retrospective review of files of patients treated for a gigantic paranasal sinus osteoma from January 2008 to December 2019. Additionally, all patients were prospectively reexamined in early 2020 for late complications or clinical recurrence. RESULTS: Ten patients were included, with a mean age of 53.8 years (range: 23-77 years). The leading presenting findings were proptosis (80%) and diplopia (70%). Transient visual impairment was remarkably frequent (30%). Five patients were managed with an open approach, two with an endoscopic, and three with a combined technique. The most common adverse characteristics that dictated the use of an open approach, alone or in combination with an endoscopic approach, were the involvement of the anterior wall of the frontal sinus (40%), erosion of its posterior wall (30%), and a far-anterior intraorbital extension (30%). No major postoperative complications were observed, and also no recurrences. CONCLUSION: Our study illustrates that these tumours may require a different management attitude. Despite substantial advances in the endoscopic management of benign sinonasal tumours, managing these massive tumours solely endoscopically could, in many cases, be inefficacious or impossible. Open approaches remain valuable, representing a safe and straightforward method for adequate exposure.
目的:鼻窦骨瘤是一种生长缓慢的良性骨肿瘤,当肿瘤大于 30mm 时,被称为“巨大型”。对于这种大小的肿瘤需要特殊考虑,由于其罕见性,其治疗方法存在很大争议。本研究通过单一机构的 12 年经验,旨在为其治疗方法提供更多的了解。
方法:回顾性分析 2008 年 1 月至 2019 年 12 月期间因巨大鼻窦骨瘤在我院治疗的患者病历。此外,所有患者在 2020 年初均进行前瞻性复查,以评估晚期并发症或临床复发情况。
结果:共纳入 10 例患者,平均年龄为 53.8 岁(范围:23-77 岁)。主要表现为眼球突出(80%)和复视(70%)。短暂性视力障碍也很常见(30%)。5 例患者采用开放入路治疗,2 例采用内镜入路,3 例采用联合技术。单独或联合内镜入路治疗的最常见不利特征是额窦前壁受累(40%)、后壁侵蚀(30%)和眶内前极延伸(30%)。未观察到重大术后并发症,也无复发。
结论:我们的研究表明,这些肿瘤可能需要不同的治疗方法。尽管内镜治疗良性鼻窦肿瘤取得了很大进展,但在许多情况下,仅采用内镜治疗这些巨大肿瘤可能无效或不可能。开放入路仍然具有价值,是一种安全且简单的充分暴露方法。
Eur Arch Otorhinolaryngol. 2021-5
Am J Rhinol Allergy. 2019-1
J Craniofac Surg. 2017-5
Otolaryngol Pol. 2007
J Craniofac Surg. 2014-7
Curr Opin Otolaryngol Head Neck Surg. 2012-2
Rev Stomatol Chir Maxillofac Chir Orale. 2016-11
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024-6
Radiol Case Rep. 2022-11-26
Int J Otolaryngol. 2022-8-25
Am J Rhinol Allergy. 2019-1
Am J Rhinol Allergy. 2015
Ophthalmic Plast Reconstr Surg. 2014
Int J Surg Case Rep. 2013
J Craniofac Surg. 2012-9